To contact the Division office, please call Adriana Fonseca at 443-287-4962.
The Division of Neurobiology has the ultimate goal of understanding the neurobiology of psychiatric diseases and translating that understanding into effective clinical treatments. It currently comprises basic science labs of six faculty members, as well as clinical research and services in Huntington’s disease. The Division has close associations with clinical and genetic research programs in schizophrenia and with imaging research programs directed at a variety of diseases. We apply modern techniques of molecular biology and genetics to the study of normal brain functioning and neuropsychiatric disorders. We are committed to applying interdisciplinary approaches in order to understand and find effective treatments for diseases affecting the brain. Some of the diseases we study include Huntington's disease, Parkinson's disease, bipolar disorder, and schizophrenia. (See also Schizophrenia Program Research)
Division faculty direct a number of basic research laboratories in behavioral, cellular, genetic, molecular, structural, and translational neurobiology.
Faculty collaborate with research being done by the Division of Psychiatric Neuroimaging on a number of disorders, especially Huntington's disease.
We offer a wide range of educational and training programs including a fellowship program, electives for residents training, and opportunities for graduate and post-graduate research.
Baltimore Huntington's Disease Center (BHDC)
This Huntington's Disease Society of America Center of Excellence at Johns Hopkins provides clinical services for Huntington's disease patients and families. These include evaluation, genetic testing and continuing care.
Opportunities are available for individuals and their families to participate in clinical research studies. Participants may receive clinical testing and other services relevant to these studies at no charge. Major funding support for the Center's on-site research programs are provided by the National Institute of Neurological Disorders and Stroke (NINDS), the High Q Foundation, the Huntington's Disease Society of America (HDSA), and the Hereditary Disease Foundation (HDF).